Services

Target ID

Identify and validate therapeutic targets with integrated data assets and AI-driven precision.

AI for Small Molecules

Elevate your small molecule discovery pipeline with AI-powered insights, from target identification to optimization.

AI for Biologics

Advance your biologics from concept to clinical readiness with AI-backed, actionable decisions.

Clinical Drug Development

Reduce costs and get more insights out of clinical data with advanced AI and ML tools.

AI & ML

Empower your drug discovery and development with data-driven decisions and customized AI & ML solutions.

Bioinformatics

Tackle the toughest research challenges with tailored bioinformatics workflows designed to fit your needs.

Data Universe

Gain access to integrated, high-quality datasets that include multi-omics, clinical trials, and meta-data.

Life Science Software Engineering

Facilitate and streamline your lab research with purpose-built software.

Bioinformatic Workflows

Transform complex biological datasets into meaningful insights with streamlined bioinformatics workflows.

Data Management

Handle data effectively and seamlessly with data management solutions that scale with your growth.
Technology

Ardigen phenAID phenotypic profiling platform

Leverage multimodal data to discover drug candidates by integrating imaging and small molecule design.

Ardigen biologics discovery platform

Accelerate your discovery with AI-powered algorithms to design, evaluate, and optimize novel biologics.
Career
About
Knowledge Hub
Contact

Services

Target ID

AI for Small Molecules

AI for Biologics

Clinical Drug Development

AI & ML

Bioinformatics

Data Universe

Life Science Software Engineering

Bioinformatic Workflows

Data Management
Technology

Ardigen phenAID phenotypic profiling platform

Ardigen biologics discovery platform
Career
About
Knowledge Hub
Contact

Knowledge hub

News

15 April 2021

Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery

News

13 April 2021

Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet

News

2 April 2021

Happy Easter holiday

News

11 March 2021

Dr. Michał Warchoł has joined the company’s Board of Management as its 4th member

News

4 February 2021

Conferences – where can you find us in February?

News

30 December 2020

Holiday Wishes

News

18 November 2020

Ardigen and The BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment.

News

13 November 2020

5 years for precision medicine – Ardigen’s anniversary

News

2 October 2020

AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2

News

1 October 2020

Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology

News

23 September 2020

Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies

News

9 July 2020

Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release

News

9 June 2020

AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients

News

8 June 2020

AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design

News

27 April 2020

Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform

News

15 April 2020

We are ready to support your efforts in the fight against COVID-19

News

18 March 2020

The microbiome as a potential weapon against novel coronavirus SARS-CoV-2

News

18 March 2020

Ardigen at AI Powered Drug Discovery and Manufacturing Conference

Knowledge hub

News

Ardigen and ImmuMap announce a research partnership for T-cell receptor discovery

Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology

Social Media

United States

European Union